All patients (n = 63) | With LAAT (n = 20, 31.7%) | Without LAAT (n = 43, 68.3%) | p-value | ||||
---|---|---|---|---|---|---|---|
Age (years) | 61.9 | (±10.9) | 62.8 | (±9.9) | 61.5 | (±11.4) | 0.67 |
Male sex | 60 | (95.2%) | 20 | (100%) | 40 | (93%) | 0.57 |
Heart rate (bpm) | 77.3 | (±10.9) | 76.0 | (±10.8) | 78.0 | (±11.1) | 0.51 |
BMI (kg/m2) | 26.2 | (±4.5) | 26.1 | (±4.7) | 26.3 | (±4.5) | 0.83 |
BSA (m2) | 1.9 | (±0.2) | 1.9 | (±0.2) | 1.9 | (±0.2) | 0.4 |
Ischaemic HF aetiology | 33 | (52.4%) | 13 | (65%) | 20 | (46.5%) | 0.17 |
Hypertension | 34 | (54%) | 11 | (55%) | 23 | (53.5%) | 0.91 |
Diabetes | 21 | (33.3%) | 5 | (25%) | 16 | (37.2%) | 0,34 |
Chronic kidney disease | 28 | (44.4%) | 9 | (45%) | 19 | (44.2%) | 0.95 |
History of stroke or TIA | 7 | (11.1%) | 3 | (15%) | 4 | (9.3%) | 0.81 |
CHA2DS2-VASc score | 3 | (2–4) | 3 | (2–5) | 3 | (2–4) | 0.65 |
NYHA class | 0.59 | ||||||
I | 0 | (0%) | 0 | (0%) | 0 | (0%) | |
II | 7 | (11.1%) | 3 | (15%) | 4 | (9.3%) | |
III | 34 | (54%) | 9 | (45%) | 25 | (58.1%) | |
IV | 22 | (34.9%) | 8 | (40%) | 14 | (32.6%) | |
Aspirin | 52 | (82.5%) | 17 | (85%) | 35 | (81.4%) | 0.99 |
Other antiplatelet agent | 11 | (17.5%) | 6 | (30%) | 5 | (11.6%) | 0.15 |
Statin | 39 | (61.9%) | 12 | (60%) | 27 | (62.8%) | 0.83 |
Diuretic | 62 | (98.4%) | 19 | (95%) | 43 | (100%) | 0.69 |
Beta-blocker | 58 | (92.1%) | 18 | (90%) | 40 | (93%) | 0.93 |
ACE-I or ARB | 43 | (68.3%) | 16 | (80%) | 27 | (62.8%) | 0.17 |
MRA | 53 | (84.1%) | 16 | (80%) | 37 | (86.1%) | 0.81 |
Calcium channel blocker | 2 | (3.2%) | 0 | (0%) | 2 | (4.7%) | 0.84 |
Digoxin | 2 | (3.2%) | 0 | (0%) | 2 | (4,7%) | 0.84 |
LA diameter (cm) | 5.0 | (±0.4) | 5.0 | (±0.3) | 5.1 | (±0.5) | 0.6 |
LAA (cm2) | 31.3 | (±7.4) | 31.1 | (±5.5) | 31.4 | (±8.1) | 1 |
LAVI (ml/m2) | 62.1 | (±13.3) | 68.6 | (±9.9) | 59.1 | (±13.7) | 0.01 |
LVEF (%) | 19.2 | (±4.1) | 18.9 | (±5) | 19.4 | (±3.7) | 0.99 |
E/A | 2.4 | (±1.1) | 2.7 | (±1.3) | 2.3 | (±1) | 0.28 |
E/e` | 24.2 | (±8.4) | 23.6 | (±8.3) | 24.5 | (±8.5) | 0.66 |
Global PALS (%) | 8.9 | (±2) | 7.2 | (±2.1) | 9.7 | (±1.3) | < 0.001 |
Global PACS (%) | −4.0 | (±1.2) | −3.6 | (±1.1) | −4.2 | (±1.2) | 0.04 |